Researchers investigate the interaction dynamics of bovine serum albumin and silica nanoparticles using spectroscopy methods.

Nanoparticles (NPs) are materials whose dimensions range from 1 to 1,000 nanometers (nm). Due to their nano-scale dimensions and tunable material ...

Alzinova AB (ALZ) announces new clinical results showing that healthy elderly people naturally have high levels of protective antibodies against toxic amyloid-ß oligomers, which are reduced in Alzheim ...

Biogen has taken up an option on a technology developed by Denali that it thinks could help improve the safety and efficacy of amyloid-targeting drugs for Alzheimer’s disease. The technology ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...

Knocking out PERK in astrocytes reduces amyloid plaque burden in 5xFAD (top). The knockouts more quickly found the escape hole in the Barnes maze test (bottom). [Courtesy of Chen et al., Neuron, 2025.

Finally, as with any beta software, it’s important to remember that bugs/glitches are expected. I haven’t had the One UI 8 beta on my Galaxy S25 long enough to tell how stable it is, ...

Research findings suggest that a new blood test for Alzheimer’s disease has shown promise in accurately identifying people with early symptoms. Experts from the Mayo Clinic in the United States ...

Beta Technologies all-electric Alia makes a historic passenger-carrying flight into New York’s John F. Kennedy International Airport (KJFK). [Courtesy: Beta Technologies] NEW YORK—Every day ...

Buoyed by data from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's drug from its Brainshuttle programme ...

Mice deficient in BACE1 (beta-site APP cleaving enzyme 1) are healthy, fertile and appear normal in gross anatomy, tissue histology, hematology and clinical chemistry. BACE1−/− mice also ...